1. Home
  2. PXLW vs XLO Comparison

PXLW vs XLO Comparison

Compare PXLW & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$5.49

Market Cap

39.1M

Sector

Technology

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.47

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
XLO
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
39.4M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
PXLW
XLO
Price
$5.49
$8.47
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$14.33
$28.00
AVG Volume (30 Days)
49.8K
149.7K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$693,000.00
$43,766,000.00
Revenue This Year
$47.19
$88.66
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.46
$0.46
52 Week High
$15.42
$9.25

Technical Indicators

Market Signals
Indicator
PXLW
XLO
Relative Strength Index (RSI) 46.23 85.75
Support Level $4.84 $0.63
Resistance Level $6.72 $9.25
Average True Range (ATR) 0.37 0.56
MACD 0.02 -0.05
Stochastic Oscillator 53.33 68.90

Price Performance

Historical Comparison
PXLW
XLO

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: